Abeona therapeutics inc. (ABEO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenues:
Revenues

-

2,998

837

-

-

-

-

-

-

-

Expenses:
Total revenues

-

-

-

889

-

-

-

-

-

-

Foundation grants

-

-

-

-

-

-

-

-

30

50

Royalties

-

-

-

-

438

327

78

93

89

76

Product sales

-

-

-

-

-

-

1,529

2,865

539

8

License revenues

-

-

-

-

602

598

435

1,446

1,181

347

Total revenues

-

-

-

-

1,040

925

2,042

4,404

1,839

481

Research and development

48,566

38,698

16,989

10,655

4,715

333

884

2,010

3,579

3,349

General and administrative

20,705

20,106

10,943

13,290

14,320

3,712

-

-

-

4,511

Product costs

-

-

-

-

-

-

125

267

148

140

Selling, general and administrative

-

-

-

-

-

-

4,834

6,024

5,755

-

Depreciation and amortization

7,819

2,360

741

825

551

11

3

419

233

238

Total expenses

77,090

61,164

28,673

-

-

-

-

-

-

-

Total expenses

-

-

-

24,770

19,586

4,056

5,846

8,720

9,715

8,238

Loss from operations

-77,090

-58,166

-27,836

-23,881

-18,546

-3,131

-3,804

-4,316

-7,876

-7,757

Interest and miscellaneous income

1,208

1,506

525

-

-

-

-

-

-

-

Interest and other expense

400

11

8

-

-

-

-

-

-

-

Interest and miscellaneous income

-

-

-

2,014

4,026

45

251

242

1,334

2,046

Interest and other expense

-

-

-

6

6

-

-

-

-

-

Interest and other expense

-

-

-

-

-

582

279

608

963

607

Warrant extension expense

-

-

-

-

-

-

-

2,316

0

-

Gain on change in fair value of derivative-warrants

-

-

-

-

-

-

271

1,236

3,580

-

Loss on change in fair value of derivative-preferred stock

-

-

-

-

-

-23,110

8,010

-4,770

1,410

-

Gain on change in fair value of derivative-warrants

-

-

-

-

-

-

-

-

-

4,621

Loss on change in fair value of derivative - preferred stock

-

-

-

-

-

-

-

-

-

5,840

Total non operating income (expense)

-

-

-

-

4,020

-23,647

8,253

-6,216

5,361

220

Net loss before state income taxes

-

-

-

-

-

-

-

-

-2,515

-7,537

State income taxes

-

-

-

-

-

-

-

-

17

0

Net loss

-76,282

-56,671

-27,319

-21,873

-14,526

-26,778

4,449

-10,532

-2,532

-7,537

Less preferred stock dividends

-

-

-

-

-

2,875

2,898

1,999

1,774

-1,791

Net loss allocable to common stockholders

-

-

-

-

-

-29,653

1,551

-12,531

-4,306

-9,328

Basic and diluted loss per common share

-1.51

-1.19

-0.66

-0.64

-0.53

-15.26

-

-

-0.22

-0.60

Weighted average number of common shares outstanding - basic and diluted

50,354

47,528

41,636

34,180

27,597

1,942

-

-

19,983

-

Basic (in dollars per share)

-

-

-

-

-

-

3.07

-0.52

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

3.04

-0.52

-

-

Basic (in shares)

-

-

-

-

-

-

504

24,178

-

-

Diluted (in shares)

-

-

-

-

-

-

509

24,178

-

-

Weighted average basic and diluted common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

15,633

Foundation Revenues [Member]
Total revenues

-

2,796

-

-

-

-

-

-

-

-

License Revenues[Member]
Total revenues

-

-

602

-

-

-

-

-

-

-

Royalties [Member]
Total revenues

-

202

235

-

-

-

-

-

-

-

Foundation revenues
Total revenues

-

-

-

0

-

-

-

-

-

-

License revenues [Member]
Total revenues

-

-

-

602

-

-

-

-

-

-

Royalties
Total revenues

-

-

-

287

-

-

-

-

-

-